Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Elutia Inc. (ELUT)

NASDAQ

$0.83

$-0.02

(-2.11%)

Previous Close: ⁦$0.84⁩

Market Closed

Elutia Inc. (ELUT) Live Price Chart

Last updated: ⁦2026-09-06 03:41:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Elutia Inc. (ELUT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.83, with a market capitalisation of $37.44M and a P/E ratio of 0.72. Over the past 52 weeks, its price has ranged from $0.50 to $2.10. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$37.44M
Open	$0.85
Day's High	$5.24
Day's Low	$0.50
Previous Close	$0.84
Volume	37.99K
Average Volume	--
P/E Ratio	0.72
52-Week High	$2.10
52-Week Low	$0.50
Dividend Yield	--
Earnings Date	--

Elutia Inc. (ELUT) Latest Closing Stock Price

Elutia Inc. (ELUT) last closed at $0.84 as of 2026-09-04 23:31:00, unchanged from the previous close of $0.84.

During the latest regular trading session, ELUT traded between $0.50 and $5.24, with a volume of 37.99K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Elutia Inc. (ELUT) 7-Day Stock Price Change

Over the past seven days, Elutia Inc. (ELUT) moved from $0.88 to $0.83, representing a decline of 5.32% ($0.05).

The stock traded between $0.82 and $0.90 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 71.91 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ELUT 52-Week Price Position

Position in Range: 20.9%

52W Low$0.50

52W High$2.10

ELUT is currently trading at $0.83, placing it 20.9% of the way from its 52-week low of $0.50 to its 52-week high of $2.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Elutia Inc. (ELUT)?

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Elutia Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	26
Exchange	NASDAQ
Company Website	https://www.elutia.com

How to Buy Elutia Inc. (ELUT) Stock on MEXC

Eligible investors can buy real shares of Elutia Inc. (ELUT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ELUT and Place Your Order

Open the RealStocks trading page and search for ELUT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Elutia Inc. (ELUT) stock price today?

Elutia Inc. (ELUT) is currently trading at $ 0.83, down 0.71% ($0.01) from the previous close of $ 0.84. Intraday prices update in real time during regular trading hours.

2.Is ELUT stock going up or down today?

As of 2026-09-04 23:31:00, ELUT is trading at $ 0.83, down 0.71% ($0.01) from its previous close of $ 0.84. The stock has traded between $ 0.50 and $ 5.24 during today’s regular session. Past price movements do not guarantee future results.

3.What is ELUT pre-market price?

As of 2026-09-04 23:31:00, ELUT is trading at $ 0.85 in pre-market trading, up 0.83% ($0.01) from the previous close of $ 0.84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ELUT after-hours price?

As of 2026-09-04 23:31:00, ELUT is trading at $ 0.83 in after-hours trading, down 1.19% ($0.01) from the regular-session close of $ 0.84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ELUT stock trading now?

ELUT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ELUT sit relative to its 52-week high and low?

Over the past 52 weeks, ELUT has traded between a low of $ 0.50 and a high of $ 2.10. At $ 0.83, the stock is positioned 20.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Elutia Inc. in?

Elutia Inc. (ELUT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Elutia Inc.'s market capitalisation and where is it listed?

Elutia Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 37.44M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ELUT valued in terms of P/E ratio and EPS?

ELUT trades at a P/E ratio of 0.72, based on trailing-twelve-month EPS of $ 1.17. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Elutia Inc. pay a dividend?

Elutia Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.